Pfizer Upgraded To Overweight; Goldman Downgrades Kimco To Sell
Finbox io | Nov 29, 2016 03:27PM ET
Here are today’s top Wall Street analyst ratings where finbox.io’s unbiased fair value estimates support the recommendation.h3 Top Upgrades/h3
- Cantor Fitzgerald raised Cognizant Technology Solutions (NASDAQ:CTSH) target price to $67 per share. Finbox.io’s fair value estimate is slightly lower at $66 per share implying 18% upside.
- Barclay's upgraded Pfizer (NYSE:PFE) from Equal Weight to Overweight. Twelve valuation models suggest the stock is currently 15% undervalued.
- Jefferies Group reiterated its Buy rating on AT&T (NYSE:T). Eleven valuation models imply a fair value of $45.50 per share representing 15% upside.
- Citigroup upgraded Zimmer Biomet (NYSE:ZBH). The rating change is supported by the company’s underlying fundamentals.
- Citigroup downgraded Science Applications International (NYSE:SAIC). Shares are currently trading at a 24% premium.
- KeyCorp downgraded Multi-Color Corp (NASDAQ:LABL) from Sector Weight to Underweight. Ten free cash flow models imply the stock is 20% overvalued.
Get The News You Want
- Barclays downgraded Johnson & Johnson (NYSE:JNJ) from Overweight to Equal Weight. Fundamentals support the rating change.
- Goldman Sachs downgraded Kimco Realty (NYSE:KIM) from Neutral to Sell. Eight valuation models support the rating and conclude a negative 14% margin of safety.
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.